CIK 0001610820
- Non-accelerated filer
- Smaller reporting company
BriaCell Therapeutics Corp.
Sign in to watch- Ticker
- BCTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jul 31
- Incorporated
- British Columbia, Canada
- Entity type
- Operating
- Phone
- +1 604-921-1810
- Business address
- 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR, WEST VANCOUVER, British Columbia, Canada, V7T 2X1
- Former names
- Ansell Capital Corp.
Securities
- BCTX Common Shares Nasdaq
- BCTXL Warrants Nasdaq
- BCTXZ Warrant Nasdaq
- DEF 14A Proxy Proxy Statement
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- DEF 14A Proxy Proxy Statement
- SC 13D/A Stake Beneficial Ownership Report
- SC 13D/A Stake Beneficial Ownership Report
- SC 13D/A Stake Beneficial Ownership Report
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13D/A Stake Beneficial Ownership Report
- DEF 14A Proxy Proxy Statement
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- DEF 14A Proxy Proxy Statement
Page 1 of 3 · 46 filings